Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

STANDARD BIOTOOLS INC. Director's Dealing 2023

May 20, 2023

32853_dirs_2023-05-19_d632e79d-7dd8-49a0-b818-8d36eb14b264.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2023-05-17

Reporting Person: Casdin Partners FO1-MSV, LP (Director)

More from STANDARD BIOTOOLS INC.

Proxy Solicitation & Information Statement 2026
Apr 27
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Feb 24
Director's Dealing 2026
Feb 24
Director's Dealing 2026
Feb 24
Regulatory Filings 2026
Feb 24
Regulatory Filings 2026
Feb 5
Regulatory Filings 2026
Jan 30
View all filings →